Most Popular in the last 30 days

Novo Nordisk to launch new connected insulin pens in 2019; partners with Dexcom, Glooko, Roche

(Ref: PR Newswire, Novo Nordisk)

Published: October 1, 2018

Tags:

Medtronic to buy Mazor Robotics for around $1.6 billion

(Ref: Globes, NASDAQ, Bloomberg, MarketWatch, CNBC, GlobeNewswire, Investor's Business Daily)

Published: September 21, 2018

Tags:

Google AI tool accurately identifies lung cancer type, genetic changes in lung tumours using images: study

(Ref: Nature Medicine, WIRED, PR Newswire)

Published: September 17, 2018

Tags:

FDA authorises first NGS-based test to detect very low levels of remaining cancer cells in ALL, multiple myeloma

(Ref: GeekWire, Business Wire, FDA)

Published: September 28, 2018

Tags:

Viewpoints: Medtronic stands RESOLUTE for the permanent-polymer DES team

(Ref: Viewpoints Desk)

Published: September 24, 2018

Tags:

Friday Five – The medtech week in review

(Ref: The Friday Five Desk)

Published: September 27, 2018

Tags:

FDA approves bicuspid TAVR study, new labelling for Medtronic's CoreValve Evolut system

(Ref: GlobeNewswire)

Published: September 18, 2018

Tags:

Abbott's MitraClip meets main goals in heart failure study of patients with secondary mitral regurgitation

(Ref: NEJM, The New York Times, NASDAQ, Cardiovascular Research Foundations, PR Newswire)

Published: September 23, 2018

Tags:

ViewPoints: Advent Access makes M&A move - astute nest-feathering or too much too soon?

(Ref: ViewPoints Desk)

Published: October 4, 2018

Tags:

The Wider View: Eluvia hogged TCT limelight, but is Boston Scientific’s Lotus set to blossom again?

(Ref: The Wider View Desk)

Published: September 25, 2018

Tags:

Boston Scientific's Eluvia drug-eluting vascular stent system gains FDA approval

(Ref: Channel News Asia, NASDAQ, Boston Scientific)

Published: September 24, 2018

Tags:

Neovasc reports positive follow-up in first US patient implanted with Reducer device

(Ref: NASDAQ, MarketWatch, Proactive Investors, PR Newswire)

Published: October 3, 2018

Tags:

One To Watch: Avisa seeks to inflate coffers for 10-minute pneumonia breath test

(Ref: One To Watch Desk)

Published: September 20, 2018

Tags:

The Wider View: Medtronic expands bicuspid TAVR labelling, but impact limited

(Ref: The Wider View Desk)

Published: September 20, 2018

Tags:

FDA approves expanded use of Qiagen's EGFR test in lung cancer

(Ref: StreetInsider.com, Markets Insider, Qiagen)

Published: September 28, 2018

Tags:

Physician Views: Will IMPERIAL's favourable Eluvia data spell a sea change in peripheral intervention?

(Ref: Physician Views Desk)

Published: October 2, 2018

Tags:

Abbott gains EU clearance for first troponin test to predict chance of heart attack in healthy adults

(Ref: PR Newswire, The Economic Times)

Published: September 27, 2018

Tags:

Stryker acquires HyperBranch Medical Technology for around $220 million

(Ref: StreetInsider, GlobeNewswire)

Published: October 1, 2018

Tags:

Myriad, Pfizer enter commercialisation plan for BRACAnalysis CDx as companion diagnostic with talazoparib

(Ref: GlobeNewswire, StreetInsider, NASDAQ)

Published: 6 days ago

Tags:

The Wider View: Allergy immunotherapy a distant memory for Circassia as NIOX and Tudorza inflates top-line growth

(Ref: The Wider View Desk)

Published: September 29, 2018

Tags:

Most Popular in the last 30 days

Novo Nordisk to launch new connected insulin pens in 2019; partners with Dexcom, Glooko, Roche

Medtronic to buy Mazor Robotics for around $1.6 billion

Google AI tool accurately identifies lung cancer type, genetic changes in lung tumours using images: study

FDA authorises first NGS-based test to detect very low levels of remaining cancer cells in ALL, multiple myeloma

Viewpoints: Medtronic stands RESOLUTE for the permanent-polymer DES team

Friday Five – The medtech week in review

FDA approves bicuspid TAVR study, new labelling for Medtronic's CoreValve Evolut system

Abbott's MitraClip meets main goals in heart failure study of patients with secondary mitral regurgitation

ViewPoints: Advent Access makes M&A move - astute nest-feathering or too much too soon?

The Wider View: Eluvia hogged TCT limelight, but is Boston Scientific’s Lotus set to blossom again?

Boston Scientific's Eluvia drug-eluting vascular stent system gains FDA approval

Neovasc reports positive follow-up in first US patient implanted with Reducer device

One To Watch: Avisa seeks to inflate coffers for 10-minute pneumonia breath test

The Wider View: Medtronic expands bicuspid TAVR labelling, but impact limited

FDA approves expanded use of Qiagen's EGFR test in lung cancer

Physician Views: Will IMPERIAL's favourable Eluvia data spell a sea change in peripheral intervention?

Abbott gains EU clearance for first troponin test to predict chance of heart attack in healthy adults

Stryker acquires HyperBranch Medical Technology for around $220 million

Myriad, Pfizer enter commercialisation plan for BRACAnalysis CDx as companion diagnostic with talazoparib

The Wider View: Allergy immunotherapy a distant memory for Circassia as NIOX and Tudorza inflates top-line growth

Tags in the News

Recent Reports